Casey Cunningham
Partner & Chief Scientific Officer @ Sante Ventures
Houston, United States
Casey Cunningham is a Series E investor at Sante Ventures in Houston focused on Beauty and Cosmetics. Casey Cunningham, MD is the Chief Scientific Officer of Santé Ventures and the Chief Medical Officer of two portfolio companies, Terapio and Molecular Templates.Dr. Cunningham received his fellowship training in oncology and hematology at the Harvard Medical School, where he subsequently served on the faculty. He was also one of the foundingmembers of the Division of Experimental Medicine at the Brigham & Women’s Hospital in Boston, where he established a basic research laboratory in Cell and Molecular Biology. Casey received his medical degree from the University of Texas Southwestern Medical School with a residency in Internal Medicine at the Medical College of Wisconsin.Casey returned to Texas and in 1999 as the Associate Director of the Mary Crowley Cancer Research Center in Dallas, a position he held until 2007. The MCCRC performs early phase drug development and Casey was the principal investigator on numerous trials, with a particular emphasis on gene and cell-based therapies. He has over 60 publications in peer-reviewed journals and many abstracts and meeting presentations.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Casey Cunningham invests in
Stages Casey Cunningham invests in
Countries Casey Cunningham invests in
Investment Focus
Industry
- Beauty 1 (33%)
- Cosmetics 1 (33%)
- Health Care 1 (33%)
Stage
- Series E 1 (33%)
- Series F 1 (33%)
- Private Equity 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Zeno Corporation
|
Zeno Corporation is the maker of health and beauty products. They specifically focus on thermal-based, over-the-counter products for skin. Their primary product is called Zeno HOT SPOT and is centered around patented technology ClearPointâ„¢ | Private Equity / Nov 09, 2009 | |
|
Zeno Corporation
|
Zeno Corporation is the maker of health and beauty products. They specifically focus on thermal-based, over-the-counter products for skin. Their primary product is called Zeno HOT SPOT and is centered around patented technology ClearPointâ„¢ | Series F / Nov 06, 2009 | |
|
Zeno Corporation
|
Zeno Corporation is the maker of health and beauty products. They specifically focus on thermal-based, over-the-counter products for skin. Their primary product is called Zeno HOT SPOT and is centered around patented technology ClearPointâ„¢ | $28M / Series E / Jul 11, 2008 |
About Sante Ventures
Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has nearly $1 billion in capital under management.
Sante Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Casey Cunningham
Partner & Chief Scientific Officer
|
|||
David Kaufman
Chief Operating Officer
|
|||
Dennis McWilliams
Managing Director
|
|||
Diane Brouilliard
Head of Talent & Networks
|
|||
Douglas French
Co-Founder and Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Casey Cunningham invest in?
Casey Cunningham invests primarily in Beauty, Cosmetics and Health Care startups, most often at Series E and Series F stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Casey Cunningham last invest?
The most recent investment recorded for Casey Cunningham closed in Nov 2009. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
